XML 74 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor and Non-Guarantor Financial Information (Tables)
9 Months Ended
Sep. 30, 2013
Supplemental Guarantor and Non-Guarantor Financial Information [Abstract]  
Condensed Consolidating Balance Sheet
Condensed Consolidating Balance Sheet
September 30, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
142,345

 
$
—

 
$
40,949

 
$
—

 
$
183,294

Receivables, net
—

 
237,240

 
24,741

 
(19,523
)
 
242,458

Deferred tax assets, net
—

 
6,069

 
2,407

 
—

 
8,476

Prepaid expenses and other current assets
—

 
34,330

 
10,497

 
—

 
44,827

Total current assets
142,345

 
277,639

 
78,594

 
(19,523
)
 
479,055

Notes receivable from CareCentrix
—

 
28,471

 
—

 
—

 
28,471

Fixed assets, net
—

 
40,858

 
567

 
—

 
41,425

Intangible assets, net
—

 
190,635

 
2,600

 
—

 
193,235

Goodwill
—

 
432,372

 
6,064

 
—

 
438,436

Investment in subsidiaries
811,716

 
28,234

 
—

 
(839,950
)
 
—

Other assets
—

 
71,441

 
5

 
—

 
71,446

Total assets
$
954,061

 
$
1,069,650

 
$
87,830

 
$
(859,473
)
 
$
1,252,068

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
18,750

 
$
—

 
$
—

 
$
—

 
$
18,750

Accounts payable
—

 
11,451

 
523

 
—

 
11,974

Other current liabilities
—

 
172,899

 
56,072

 
(19,523
)
 
209,448

Total current liabilities
18,750

 
184,350

 
56,595

 
(19,523
)
 
240,172

Long-term debt
891,432

 
—

 
—

 
—

 
891,432

Deferred tax liabilities, net
—

 
31,734

 
—

 
—

 
31,734

Other liabilities
—

 
41,850

 
1

 
—

 
41,851

Total Gentiva shareholders’ equity
43,879

 
811,716

 
28,234

 
(839,950
)
 
43,879

Noncontrolling interests
—

 
—

 
3,000

 
—

 
3,000

Total equity
43,879

 
811,716

 
31,234

 
(839,950
)
 
46,879

Total liabilities and equity
$
954,061

 
$
1,069,650

 
$
87,830

 
$
(859,473
)
 
$
1,252,068


Condensed Consolidating Balance Sheet
December 31, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
166,140

 
$
—

 
$
40,912

 
$
—

 
$
207,052

Receivables, net
—

 
245,191

 
19,744

 
(13,855
)
 
251,080

Deferred tax assets, net
—

 
10,280

 
1,983

 
—

 
12,263

Prepaid expenses and other current assets
—

 
36,899

 
8,733

 
—

 
45,632

Total current assets
166,140

 
292,370

 
71,372

 
(13,855
)
 
516,027

Notes receivable from CareCentrix
—

 
28,471

 
—

 
—

 
28,471

Fixed assets, net
—

 
41,066

 
348

 
—

 
41,414

Intangible assets, net
—

 
193,513

 
100

 
—

 
193,613

Goodwill
—

 
650,300

 
6,064

 
—

 
656,364

Investment in subsidiaries
1,002,204

 
27,210

 
—

 
(1,029,414
)
 
—

Other assets
—

 
75,039

 
6

 
—

 
75,045

Total assets
$
1,168,344

 
$
1,307,969

 
$
77,890

 
$
(1,043,269
)
 
$
1,510,934

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
25,000

 
$
—

 
$
—

 
$
—

 
$
25,000

Accounts payable
—

 
27,300

 
—

 
(13,855
)
 
13,445

Other current liabilities
—

 
202,321

 
49,133

 
—

 
251,454

Total current liabilities
25,000

 
229,621

 
49,133

 
(13,855
)
 
289,899

Long-term debt
910,182

 
—

 
—

 
—

 
910,182

Deferred tax liabilities, net
—

 
42,165

 
—

 
—

 
42,165

Other liabilities
—

 
33,979

 
9

 
—

 
33,988

Total Gentiva shareholders’ equity
233,162

 
1,002,204

 
27,210

 
(1,029,414
)
 
233,162

Noncontrolling interests
—

 
—

 
1,538

 
—

 
1,538

Total equity
233,162

 
1,002,204

 
28,748

 
(1,029,414
)
 
234,700

Total liabilities and equity
$
1,168,344

 
$
1,307,969

 
$
77,890

 
$
(1,043,269
)
 
$
1,510,934

Condensed Consolidating Statement of Comprehensive Income
Condensed Consolidating Statement of Comprehensive Income
For the Three Months Ended September 30, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$
—

 
$
398,047

 
$
16,429

 
$
(3,984
)
 
$
410,492

Cost of services sold
—

 
212,543

 
11,919

 
(3,984
)
 
220,478

Gross profit
—

 
185,504

 
4,510

 
—

 
190,014

Selling, general and administrative expenses
—

 
(155,861
)
 
(4,959
)
 
—

 
(160,820
)
Interest (expense) and other, net
(22,355
)
 
—

 
13

 
—

 
(22,342
)
Equity in earnings of subsidiaries
16,144

 
(459
)
 
—

 
(15,685
)
 
—

(Loss) income before income taxes
(6,211
)
 
29,184

 
(436
)
 
(15,685
)
 
6,852

Income tax benefit (expense)
9,931

 
(13,040
)
 
65

 
—

 
(3,044
)
Net income
3,720

 
16,144

 
(371
)
 
(15,685
)
 
3,808

Noncontrolling interests
—

 
—

 
(88
)
 
—

 
(88
)
Net income attributable to Gentiva shareholders
$
3,720

 
$
16,144

 
$
(459
)
 
$
(15,685
)
 
$
3,720

Comprehensive income
$
3,720

 
$
16,144

 
$
(371
)
 
$
(15,685
)
 
$
3,808

Condensed Consolidating Statement of Comprehensive Income
For the Three Months Ended September 30, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$
—

 
$
412,963

 
$
14,186

 
$
(2,705
)
 
$
424,444

Cost of services sold
—

 
217,767

 
8,827

 
(2,705
)
 
223,889

Gross profit
—

 
195,196

 
5,359

 
—

 
200,555

Selling, general and administrative expenses
—

 
(156,771
)
 
(4,436
)
 
—

 
(161,207
)
Goodwill, intangibles and other long-lived asset impairment
—

 
(19,132
)
 
—

 
—

 
(19,132
)
Interest (expense) and other, net
(22,917
)
 
—

 
23

 
—

 
(22,894
)
Equity in earnings of subsidiaries
12,563

 
243

 
—

 
(12,806
)
 
—

(Loss) income before income taxes and equity in net earnings of CareCentrix
(10,354
)
 
19,536

 
946

 
(12,806
)
 
(2,678
)
Income tax benefit (expense)
9,831

 
(7,979
)
 
(555
)
 
—

 
1,297

Equity in net earnings of CareCentrix
—

 
1,006

 
—

 
—

 
1,006

Net (loss) income
(523
)
 
12,563

 
391

 
(12,806
)
 
(375
)
Noncontrolling interests
—

 
—

 
(148
)
 
—

 
(148
)
Net (loss) income attributable to Gentiva shareholders
$
(523
)
 
$
12,563

 
$
243

 
$
(12,806
)
 
$
(523
)
Comprehensive (loss) income
$
(523
)
 
$
12,563

 
$
391

 
$
(12,806
)
 
$
(375
)
Condensed Consolidating Statement of Comprehensive Income
For the Nine Months Ended September 30, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$
—

 
$
1,203,258

 
$
48,498

 
$
(11,249
)
 
$
1,240,507

Cost of services sold
—

 
638,418

 
33,829

 
(11,249
)
 
660,998

Gross profit
—

 
564,840

 
14,669

 
—

 
579,509

Selling, general and administrative expenses
—

 
(468,270
)
 
(14,364
)
 
—

 
(482,634
)
Goodwill and other long-lived asset impairment
—

 
(224,320
)
 
—

 
—

 
(224,320
)
Interest (expense) and other, net
(66,829
)
 
—

 
46

 
—

 
(66,783
)
Equity in earnings of subsidiaries
(156,813
)
 
(7
)
 
—

 
156,820

 
—

(Loss) income before income taxes
(223,642
)
 
(127,757
)
 
351

 
156,820

 
(194,228
)
Income tax benefit (expense)
26,532

 
(29,056
)
 
67

 
—

 
(2,457
)
Net (loss) income
(197,110
)
 
(156,813
)
 
418

 
156,820

 
(196,685
)
Noncontrolling interests
—

 
—

 
(425
)
 
—

 
(425
)
Net (loss) income attributable to Gentiva shareholders
$
(197,110
)
 
$
(156,813
)
 
$
(7
)
 
$
156,820

 
$
(197,110
)
Comprehensive (loss) income
$
(197,110
)
 
$
(156,813
)
 
$
418

 
$
156,820

 
$
(196,685
)
Condensed Consolidating Statement of Comprehensive Income
For the Nine Months Ended September 30, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$
—

 
$
1,253,781

 
$
42,429

 
$
(8,423
)
 
$
1,287,787

Cost of services sold
—

 
661,151

 
26,759

 
(8,423
)
 
679,487

Gross profit
—

 
592,630

 
15,670

 
—

 
608,300

Selling, general and administrative expenses
—

 
(486,285
)
 
(12,557
)
 
—

 
(498,842
)
Goodwill, intangibles and other long-lived asset impairment
—

 
(19,132
)
 
—

 
—

 
(19,132
)
Gain on sale of businesses
—

 
5,449

 
(2
)
 
—

 
5,447

Interest (expense) and other, net
(67,138
)
 
—

 
87

 
—

 
(67,051
)
Equity in earnings of subsidiaries
50,166

 
1,260

 
—

 
(51,426
)
 
—

(Loss) income before income taxes and equity in net earnings of CareCentrix
(16,972
)
 
93,922

 
3,198

 
(51,426
)
 
28,722

Income tax benefit (expense)
35,198

 
(44,762
)
 
(1,314
)
 
—

 
(10,878
)
Equity in net earnings of CareCentrix
—

 
1,006

 
—

 
—

 
1,006

Net income
18,226

 
50,166

 
1,884

 
(51,426
)
 
18,850

Noncontrolling interests
—

 
—

 
(624
)
 
—

 
(624
)
Net income attributable to Gentiva shareholders
$
18,226

 
$
50,166

 
$
1,260

 
$
(51,426
)
 
$
18,226

Comprehensive income
$
18,226

 
$
50,166

 
$
1,884

 
$
(51,426
)
 
$
18,850

Condensed Consolidating Statement of Cash Flows
Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2013
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(24,718
)
 
$
41,545

 
$
3,038

 
$
(1,296
)
 
$
18,569

INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets
—

 
(13,872
)
 
(342
)
 
—

 
(14,214
)
Proceeds from sale of businesses
—

 
508

 
—

 
—

 
508

Acquisition of businesses
—

 
(4,538
)
 
(2,500
)
 
2,400

 
(4,638
)
Net cash (used in) provided by investing activities
—

 
(17,902
)
 
(2,842
)
 
2,400

 
(18,344
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
2,459

 
—

 
—

 
—

 
2,459

Windfall tax benefits associated with equity-based compensation
92

 
—

 
—

 
—

 
92

Payment of contingent consideration accrued at acquisition date
—

 
(1,675
)
 
—

 
—

 
(1,675
)
Intercompany dividend
2,300

 
—

 
(2,300
)
 
—

 
—

Repayment of long-term debt
(25,000
)
 
—

 
—

 
—

 
(25,000
)
Debt issuance costs
(449
)
 
—

 
—

 
—

 
(449
)
Minority interest capital contribution
—

 
—

 
1,600

 
—

 
1,600

Majority interest capital contribution
—

 
—

 
2,400

 
(2,400
)
 
—

Distribution to minority interests
—

 
—

 
(563
)
 
—

 
(563
)
Distribution to majority interests
—

 
—

 
(1,296
)
 
1,296

 
—

Other
(416
)
 
(31
)
 
—

 
—

 
(447
)
Net payments related to intercompany financing
21,937

 
(21,937
)
 
—

 
—

 
—

Net cash provided by (used in) financing activities
923

 
(23,643
)
 
(159
)
 
(1,104
)
 
(23,983
)
Net change in cash and cash equivalents
(23,795
)
 
—

 
37

 
—

 
(23,758
)
Cash and cash equivalents at beginning of period
166,140

 
—

 
40,912

 
—

 
207,052

Cash and cash equivalents at end of period
$
142,345

 
$
—

 
$
40,949

 
$
—

 
$
183,294


Condensed Consolidating Statement of Cash Flows
For the Nine Months Ended September 30, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
3,710

 
$
66,138

 
$
4,793

 
$
—

 
$
74,641

INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets
—

 
(9,188
)
 
(47
)
 
—

 
(9,235
)
Proceeds from sale of businesses
—

 
5,720

 
—

 
—

 
5,720

Acquisition of businesses
—

 
(22,520
)
 
—

 
—

 
(22,520
)
Net cash used in investing activities
—

 
(25,988
)
 
(47
)
 
—

 
(26,035
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
2,421

 
—

 
—

 
—

 
2,421

Repayment of long-term debt
(50,000
)
 
—

 
—

 
—

 
(50,000
)
Debt issuance costs
(4,125
)
 
—

 
—

 
—

 
(4,125
)
Repurchase of common stock
(4,974
)
 
—

 
—

 
—

 
(4,974
)
Distribution to minority interests
—

 
—

 
(685
)
 
—

 
(685
)
Other
3,395

 
(28
)
 
(3,473
)
 
—

 
(106
)
Net payments related to intercompany financing
40,122

 
(40,122
)
 
—

 
—

 
—

Net cash used in financing activities
(13,161
)
 
(40,150
)
 
(4,158
)
 
—

 
(57,469
)
Net change in cash and cash equivalents
(9,451
)
 
—

 
588

 
—

 
(8,863
)
Cash and cash equivalents at beginning of period
124,101

 
—

 
40,811

 
—

 
164,912

Cash and cash equivalents at end of period
$
114,650

 
$
—

 
$
41,399

 
$
—

 
$
156,049